The most important opportunity is cancer treatment, through a drug called Azixa. We expect Phase II results in late 2009. Azixa is currently being tested on an aggressive type of brain cancer and a type of aggressive melanoma that has metastasized into the brain. However, the technology may prove effective for a variety of tumor types. The reason for focusing on the brain is that the drug demonstrated an ability to naturally concentrate itself there, providing greater therapeutic benefits